Six months after the second dose, the Pfizer Inc / BioNTech SE vaccine’s effectiveness in preventing infection by the coronavirus fell to 47% from 88%, according to data published on Monday by US health agencies when deciding whether booster shots were needed. Ahead of peer review in August, the study’s findings were made public in […]